287 related articles for article (PubMed ID: 30084972)
1. CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10.
Huang X; Wu BP; Nguyen D; Liu YT; Marani M; Hench J; Bénit P; Kozjak-Pavlovic V; Rustin P; Frank S; Narendra DP
Hum Mol Genet; 2018 Nov; 27(22):3881-3900. PubMed ID: 30084972
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions.
Burstein SR; Valsecchi F; Kawamata H; Bourens M; Zeng R; Zuberi A; Milner TA; Cloonan SM; Lutz C; Barrientos A; Manfredi G
Hum Mol Genet; 2018 Jan; 27(1):160-177. PubMed ID: 29112723
[TBL] [Abstract][Full Text] [Related]
3. Loss of CHCHD2 and CHCHD10 activates OMA1 peptidase to disrupt mitochondrial cristae phenocopying patient mutations.
Liu YT; Huang X; Nguyen D; Shammas MK; Wu BP; Dombi E; Springer DA; Poulton J; Sekine S; Narendra DP
Hum Mol Genet; 2020 Jun; 29(9):1547-1567. PubMed ID: 32338760
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications.
Zhou W; Ma D; Tan EK
Neuroscientist; 2020 Apr; 26(2):170-184. PubMed ID: 31526091
[No Abstract] [Full Text] [Related]
5. PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
Zhou W; Ma D; Sun AX; Tran HD; Ma DL; Singh BK; Zhou J; Zhang J; Wang D; Zhao Y; Yen PM; Goh E; Tan EK
Hum Mol Genet; 2019 Apr; 28(7):1100-1116. PubMed ID: 30496485
[TBL] [Abstract][Full Text] [Related]
6. Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
Imai Y; Meng H; Shiba-Fukushima K; Hattori N
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791515
[TBL] [Abstract][Full Text] [Related]
7. Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS.
Straub IR; Janer A; Weraarpachai W; Zinman L; Robertson J; Rogaeva E; Shoubridge EA
Hum Mol Genet; 2018 Jan; 27(1):178-189. PubMed ID: 29121267
[TBL] [Abstract][Full Text] [Related]
8. CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy.
Shammas MK; Huang TH; Narendra DP
Biochem Soc Trans; 2023 Apr; 51(2):797-809. PubMed ID: 37021679
[TBL] [Abstract][Full Text] [Related]
9. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.
Bannwarth S; Ait-El-Mkadem S; Chaussenot A; Genin EC; Lacas-Gervais S; Fragaki K; Berg-Alonso L; Kageyama Y; Serre V; Moore DG; Verschueren A; Rouzier C; Le Ber I; Augé G; Cochaud C; Lespinasse F; N'Guyen K; de Septenville A; Brice A; Yu-Wai-Man P; Sesaki H; Pouget J; Paquis-Flucklinger V
Brain; 2014 Aug; 137(Pt 8):2329-45. PubMed ID: 24934289
[TBL] [Abstract][Full Text] [Related]
10. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients.
Chaussenot A; Le Ber I; Ait-El-Mkadem S; Camuzat A; de Septenville A; Bannwarth S; Genin EC; Serre V; Augé G; ; Brice A; Pouget J; Paquis-Flucklinger V
Neurobiol Aging; 2014 Dec; 35(12):2884.e1-2884.e4. PubMed ID: 25155093
[TBL] [Abstract][Full Text] [Related]
11. Loss of mitochondrial Chchd10 or Chchd2 in zebrafish leads to an ALS-like phenotype and Complex I deficiency independent of the mitochondrial integrated stress response.
Petel Légaré V; Rampal CJ; Gurberg TJN; Aaltonen MJ; Janer A; Zinman L; Shoubridge EA; Armstrong GAB
Dev Neurobiol; 2023 Jan; 83(1-2):54-69. PubMed ID: 36799027
[TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of CHCHD2 and CHCHD10 in Italian patients with Parkinson's disease.
Rubino E; Brusa L; Zhang M; Boschi S; Govone F; Vacca A; Gai A; Pinessi L; Lopiano L; Rogaeva E; Rainero I
Neurobiol Aging; 2017 May; 53():193.e7-193.e8. PubMed ID: 28108040
[TBL] [Abstract][Full Text] [Related]
13. Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.
Genin EC; Bannwarth S; Lespinasse F; Ortega-Vila B; Fragaki K; Itoh K; Villa E; Lacas-Gervais S; Jokela M; Auranen M; Ylikallio E; Mauri-Crouzet A; Tyynismaa H; Vihola A; Augé G; Cochaud C; Sesaki H; Ricci JE; Udd B; Vives-Bauza C; Paquis-Flucklinger V
Neurobiol Dis; 2018 Nov; 119():159-171. PubMed ID: 30092269
[TBL] [Abstract][Full Text] [Related]
14. ALS and Parkinson's disease genes CHCHD10 and CHCHD2 modify synaptic transcriptomes in human iPSC-derived motor neurons.
Harjuhaahto S; Rasila TS; Molchanova SM; Woldegebriel R; Kvist J; Konovalova S; Sainio MT; Pennonen J; Torregrosa-Muñumer R; Ibrahim H; Otonkoski T; Taira T; Ylikallio E; Tyynismaa H
Neurobiol Dis; 2020 Jul; 141():104940. PubMed ID: 32437855
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of CHCHD2 and CHCHD10 in Italian patients with mitochondrial myopathy.
Rubino E; Zhang M; Mongini T; Boschi S; Vercelli L; Vacca A; Govone F; Gai A; Giordana MT; Grinberg M; Rogaeva E; Rainero I
Neurobiol Aging; 2018 Jun; 66():181.e1-181.e2. PubMed ID: 29519717
[TBL] [Abstract][Full Text] [Related]
16. ALS/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response.
Anderson CJ; Bredvik K; Burstein SR; Davis C; Meadows SM; Dash J; Case L; Milner TA; Kawamata H; Zuberi A; Piersigilli A; Lutz C; Manfredi G
Acta Neuropathol; 2019 Jul; 138(1):103-121. PubMed ID: 30877432
[TBL] [Abstract][Full Text] [Related]
17. CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.
Mao C; Wang H; Luo H; Zhang S; Xu H; Zhang S; Rosenblum J; Wang Z; Zhang Q; Tang M; Shepard MJ; Wang X; Wang Y; Zhuang Z; Shi C; Xu Y
Neurobiol Aging; 2019 Mar; 75():38-41. PubMed ID: 30530185
[TBL] [Abstract][Full Text] [Related]
18. CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response.
Ruan Y; Hu J; Che Y; Liu Y; Luo Z; Cheng J; Han Q; He H; Zhou Q
Cell Death Dis; 2022 Feb; 13(2):156. PubMed ID: 35173147
[TBL] [Abstract][Full Text] [Related]
19. TDP-43 and PINK1 mediate CHCHD10
Baek M; Choe YJ; Bannwarth S; Kim J; Maitra S; Dorn GW; Taylor JP; Paquis-Flucklinger V; Kim NC
Nat Commun; 2021 Mar; 12(1):1924. PubMed ID: 33772006
[TBL] [Abstract][Full Text] [Related]
20. CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia.
Liu T; Woo JA; Bukhari MZ; LePochat P; Chacko A; Selenica MB; Yan Y; Kotsiviras P; Buosi SC; Zhao X; Kang DE
FASEB J; 2020 Jun; 34(6):8493-8509. PubMed ID: 32369233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
